Men considering a hypothetical treatment for prostate cancer: a comparison to patients
- PMID: 16257170
- DOI: 10.1016/j.pec.2005.02.002
Men considering a hypothetical treatment for prostate cancer: a comparison to patients
Abstract
Background: In facilitating informed decision making about PSA screening, men are often asked to consider the potential consequences of the test, including a diagnosis of prostate cancer and how they would want to be treated. However, there is no empirical evidence thus far demonstrating that men are able to consider this hypothetical situation in a realistic manner.
Purpose: To compare the features (attributes) of treatments that are important to non-patient men considering a hypothetical diagnosis of prostate cancer with those deemed important to men actually diagnosed with early-stage disease.
Methods: Two groups of men went through a decision aid interview to help them choose between treatment options for early-stage prostate cancer: non-patient men who imagined themselves to be diagnosed with the disease, and newly diagnosed patients. During the interview participants identified features of the treatment and disease that were important to their decisions.
Results: The percentage of non-patients and patients that thought particular attributes were important was correlated: r (33) = 0.77, p < 0.01. The effects on bladder and bowel functioning were considered important to >or=50% of each group. In addition to the 22 attributes initially presented, 49% of non-patients and 67% of patients identified additional attributes as being important to their decision. Eight (42%) of the 19 additional attributes were identified by non-patients and patients alike.
Conclusions: The group of non-patient men provided a close approximation to the group of newly diagnosed men with respect to the attributes identified as being important to their treatment decisions for early-stage prostate cancer, suggesting that the consideration of what is important to the decision by non-patient men is realistic.
Similar articles
-
Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.Patient Educ Couns. 2006 Nov;63(3):367-79. doi: 10.1016/j.pec.2006.05.005. Epub 2006 Jul 27. Patient Educ Couns. 2006. PMID: 16875796 Clinical Trial.
-
Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?J Fam Pract. 1999 Sep;48(9):682-8. J Fam Pract. 1999. PMID: 10498074
-
Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.Eur J Cancer. 2010 Feb;46(3):669-77. doi: 10.1016/j.ejca.2009.11.022. Eur J Cancer. 2010. PMID: 20022239
-
Current decision-making in prostate cancer therapy.Curr Opin Urol. 2008 May;18(3):275-8. doi: 10.1097/MOU.0b013e3282fba5f2. Curr Opin Urol. 2008. PMID: 18382237 Review.
-
Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance.BJU Int. 2007 Sep;100(3):544-51. doi: 10.1111/j.1464-410X.2007.06981.x. Epub 2007 May 26. BJU Int. 2007. PMID: 17532857 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous